India
oi-Madhuri Adnal
Hyderabad, June 30: India’s Bharat Biotech said on Wednesday it followed a “step-by-step” approach for the regulatory approval and supply contract of its COVID-19 vaccine in Brazil, and that it has not received advance payments from the Brazilian health ministry.
The Brazilian government, which agreed to purchase 20 million doses of Bharat Biotechs COVID-19 vaccine Covaxin, on Wednesday announced suspension of the contract following allegations of irregularities in the deal.
“By recommendation of @CGUonline, we decided to temporarily suspend the Covaxin contract. According to CGU”s preliminary analysis, there are no irregularities in the contract, but, due to compliance, the @minsaude opted to suspend the contract for further analysis,” Brazil Health Minister Marcelo Queiroga tweeted.
Brazil to suspend Covaxin vaccine deal amid graft probe
The Covaxin contract to Brazil landed…
